Journals / Endokrinolojide Diyalog Dergisi / 2012 / Cilt: 9 - Sayı: 3

Parathyroidectomy under sedation with local anesthesia in patients with secondary hyperparathyroidism due to adenoma localized in one lobe

Tek lobda lokalize adenoma bağlı sekonder hiperparatiroidizmde sedasyon ve lokal anestezi ile paratiroidektomi

Pages
113–118
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It shortens the hospitalization time of patients who undergo surgery for secondary hyperparathyroid adenomas localized in one lobe.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Secondary hyperparathyroidism is a serious complication of end stage renal failure.
📊
Key Findings & Data:Material and methods: The records of 10 patients with secondary hyperparathyroidism who had undergone parathyroidectomy under sedation with local anesthesia during the time period between 2007 and 2011.were retrospectively evaluated Results: Male/female ratio of the patient group was 3/7, and their mean age was 48.5±10.8 (30-62) years.
💡
Conclusion & Impact:It shortens the hospitalization time of patients who undergo surgery for secondary hyperparathyroid adenomas localized in one lobe.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Secondary hyperparathyroidism is a serious complication of end stage renal failure. In this study, we aimed to investigate the technical features, pathologic findings and follow-up outcomes of parathyroidectomy under sedation with local anesthesia in patients with secondary hyperparathyroidism due to adenoma localized in one lobe. Material and methods: The records of 10 patients with secondary hyperparathyroidism who had undergone parathyroidectomy under sedation with local anesthesia during the time period between 2007 and 2011.were retrospectively evaluated Results: Male/female ratio of the patient group was 3/7, and their mean age was 48.5±10.8 (30-62) years. The most common localization of the adenoma was the right inferior lobe (40%). The most common clinical finding was muscle weakness (90%). Preoperative laboratory tests revealed high levels of parathormon, calcium, phosphorus, and alkaline phosphate. In all patients parathyroid pathology was detected by ultrasonography and parathyroid sintigraphy. Mean operation time was 25.3 ±12.5 (15-39) minutes. 24 hours after surgery, parathormon levels returned to normal in all but one patient. Hypocalcamia developed in 7 patients (70%). Mean hospitalization time was 1.1 ±0.3(1-2) days. Hematoma due to hemorrhage occurred in 1 patient and was successfully drained. None of the patients developed laryngeal recurrent nerve injury. Median follow-up time was 17 (4-48) months. Recurrence was observed in two patients in the follow-up period. Conclusion: Parathyroidectomy under sedation with local anesthesia is a safe and relatively less traumatic intervention. It shortens the hospitalization time of patients who undergo surgery for secondary hyperparathyroid adenomas localized in one lobe.

Özet

Amaç: Son dönem böbrek yetmezliğine bağlı gelişen sekonder hiperparatiroidizm ciddi bir komplikasyondur. Bu çalışmada tek lobda lokalize sekonder hiperparatiroidizmli hastalarda sedasyon ve lokal anestezi altında paratiroidektomi yönteminin teknik detaylarının, patolojik ve takip sonuçlarının değerlendirilmesi amaçlandı. Gereç ve yöntem: 2007 2011 tarihleri arasında lokal anestezi ve sedasyon altında paratiroidektomi uygulanan sekonder hiperparatiroidizm tanılı 10 hasta retrospektif incelendi. Bulgular: Hastaların 7 (%70)si kadın ve 3 (%30)'ü erkek olup, yaş ortalaması 48.5±10.8 (30-62) yıl idi. Sekonder hiperparatiroidizme yol açan patolojiler tek lobda lokalize idi. Hastaların %40ında sık lokalizasyon sağ alt lobdaydı. Hastalarda en sık klinik bulgu kas güçsüzlüğü idi (%90 oranında). Preoperatif dönemde parathormon, kalsiyum, fosfor ve alkalen fosfataz değerleri yüksek idi. Postoperatif 24. saatte laboratuar tetkiklerinde bir hasta hariç paratiroid hormonu arzu edilen değerlere geldi. Hastaların 7sinde (%70) ameliyat sonrası dönemde hipokalsemi gelişti. Preoperatif dönemde boyun ultrasonografi ve paratiroid sintigrafi ile paratiroid patolojisini saptama oranı %100 idi. Hastaların ortalama ameliyat süresi 25.3 ±12.5 (15-39) dakika ve hastanede ortalama yatış süreleri 1.1 ±0.3 (1-2) gün idi. Postoperatif dönemde bir hastada hemorajiye bağlı hematom gelişti ve hematom drene edildi. Hiçbir hastada postoperatif dönemde rekürrens sinir zedelenmesi gözlenmedi. Hastalar medyan 17 (4-48) ay takip edildi. Bu süre zarfında hastaların 2sinde (%20) nüks gelişti. Sonuç: Tek lobda lokalize sekonder paratiroid adenomlarının tedavisinde sedasyon ve lokal anestezi altında paratiroidektomi; güvenli, nispeten az travmatik, hastanede kalış süresini kısaltan ve bu nedenlerle uygulanabilir bir girişimdir.

🔖

Cite This Article

GİRGİN, S., ÖNDER, A., KAPAN, M., ALİOSMANOĞLU, İ., ARIKANOĞLU, Z., TAŞKESEN, F., BAŞOL, Ö., GÜL, M. (2022). Parathyroidectomy under sedation with local anesthesia in patients with secondary hyperparathyroidism due to adenoma localized in one lobe. Endokrinolojide Diyalog Dergisi, Cilt: 9 - Sayı: 3, 113–118. https://ajindex.com/articles/500723

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Block GA, Port FK. Re-evaluation of risk associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendation for a change in management. Am J Kidney Dis 2000;35(6):1226–37
  2. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO4, Ca3PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12(10):2131–38
  3. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31(4):607–17
  4. Sadler GP, Clark OH, van Herden JA, Farley DR. Thyroid and parathyroid. In: Schwartz SI, Shires GT, Daly JM, Fisher JE, Galloway AC (Eds). Principles of Surgery. 7th ed. New York. Mc Graw Hill, 1999:pp 1706-7
  5. Malluche HH, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int 1992;42(38):62-7. 6. de Francisco AL, Fresnedo GF, Rodrigo E, Piñera C, Amado JA, Arias M. Parathyroidectomy in dialysis patients. Kidney Int 2002;61(80);161-6
  6. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4):1–202
  7. Erikoğlu M, Tavlı Ş, Türk S, Tekin Ş. Sekonder hiperparatiroidili hastalarda subtotal paratiroidektomi sonuçlarımız. Genel Tıp Derg 2005;15(4):143-6
  8. Gogusev J, Duchambon P, Hory B et al. Depressed expression of calcium receptor in para-thyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997;51(1):328–36
  9. Ekici Y, Pehlivan S, Karakayalı FY ve ark. Effectiveness of subtotal parathyroidectomy for secondary hyperparathyroidism: Results from a single center. Turkish Journal of Surgery 2007;23(2):41-5
  10. Sezer A, İrfanoğlu ME. Surgical management of secondary hyperparathyroidism in patients with end-stage renal disease: Surgical approaches and report of cases. Trakya Univ Tip Fak Derg 2009;26(4):331-7
  11. Packman KS, Demeure MJ. Indications for parathyroidectomy and for extent of treatment for patients with secondary hyperparathyroidism. Surg Clin North Am 1995;75(3):465-82
  12. Gonzales EA, Martin KJ. Renal osteodystrophy. Pathogenesis and management. Nephrol Dial Transplant 1995;10(3):13-21
  13. Spindler A, Paz S, Berman A, et al. Muscular strength and bone mineral density in haemodialysis patients. Nephrol Dial Transplant 1997;12(1):128-32
  14. Gonnelli S, Ce